International Conferences

Recommended Conferences for Neuropsychopharmacology

Neuropsychopharmacology

Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums.

Neuropsychopharmacology, a disciplinary science related to psychopharmacology and neuroscience, which is the study of the neural mechanisms that drugs act upon to effect activity. Neuropsychopharmacology explains psychopharmacology in the areas brain functioning. Developments in Neuro psycho pharmacology directly show impact on the research of anxiety disorders, psychotic diseases, and neurodegenerative disorders.

OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals and organizes over more than 1000 Global Events annually. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 75000+ eminent personalities that ensure a quality and quick review process checker. 

Neuropsychopharmacology relates to clinical and basic science collaborations that advance our functioning of the brain and behaviour, especially as related to the physiological and psychological properties of agents acting within the CNS and the identification of the new molecular targets for the development of the second generation drugs. Developments in neuropsychopharmacology directly impact the studies of anxiety disorders, affective disorders, psychotic disorders, degenerative disorders, eating behaviour, and sleep behaviour. By the 20th century, the essential work of all the central features of neurotransmission had been gained.

List of Best International Conferences:

• 5^th Neurology Congress, March 14-16, 2016 London, UK
• 2^nd Brain Disorders Conference, October 27-29, 2016 Chicago, USA
• 2^nd Neurological Disorders and Stroke Conference, April 28-30, 2016 Dubai, UAE
• 6^th Neurological Conference, May 19-20, 2016 San Antonio, USA
• 2^nd Parkinson’s Disease and Movement Disorders Conference, November 28-30, 2016 Chicago, USA
• 4^th Vascular Dementia Conference, June 30-July 2, 2016 Valencia, Spain
• 5^th Alzheimer’s Disease and Dementia Conference, September 29-Oct 1, 2016 London, UK
• 2^nd Adolescent Medicine and Child Psychology Conference, August 29- 31, 2016 Atlanta, USA
• 2^nd Depression, Anxiety and Stress Management Meeting, November 3-4, 2016 Valencia, Spain
• 2^nd Sleep Disorders Conference, November 28- 30, 2016 Chicago, USA
• 8^th Neuroscience and Biological Psychiatry Conference
• 9^th Neuroscience and Biological Psychiatry Conference
• Neuroscience and Biological Psychiatry Symposium "TRANSLATIONAL NEUROSCIENCE OF STRESS conference
• World Psychiatric Association International Congress

Research of neuropsychopharmacology comes from basis of activities in neuroscience and clinical studies. This has motivated organizations such as the American College of Neuropsychopharmacology, the European College of Neuropsychopharmacology, and the Collegium International Neuro-psychopharmacologicum to be established for focus. The ECNP published European Neuropsychopharmacology, part of the Reed Elsevier Group, the ACNP publishes the journal Neuropsychopharmacology, and the CINP publishes the journal International Journal of Neuropsychopharmacology with Cambridge University Press. In 2002, the most recent comprehensive collected work of the ACNP, Neuropsychopharmacology is the Fifth Generation of Progress was compiled. It is one measure of the current state of knowledge, and might be said to represent a landmark in the century-long goal to establish the basic neuron-biological principles which govern the actions of the brain.

This page will be updated regularly.

This page was last updated on April 25, 2024